Legal Representation
Attorney
George Faines
USPTO Deadlines
Next Deadline
1202 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230516)
Due Date
May 16, 2029
Grace Period Ends
November 16, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 16, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| May 16, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Feb 28, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 28, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 8, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 21, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 14, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 14, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 14, 2023 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 14, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jan 11, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 12, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 11, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Non-prescription, diagnostic, at-home test kits comprised primarily of a sterile nasal swab for medical purposes for self-sampling and also including a fluid collection tube with specimen preservation solution, printed registration instruction pamphlet for how to receive secure lab results delivery online, and overnight return plastic shipping bag for transmitting medical specimens, for lab-certified testing of bodily fluids for use in disease detection, namely, SARS-CoV-2, the virus that causes COVID-19; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, SARS-CoV-2, the virus that causes COVID-19; Diagnostic kits comprised primarily of medical diagnostic assays and reagents, that can be purchased over the counter, for rapid, at-home testing of bodily fluids for use in detecting and monitoring diseases, namely, SARS-CoV-2, the virus that causes COVID-19; Specimen collection kits for use in virus testing comprised primarily of a swab for medical purposes and also including a fluid collection tube with specimen preservation solution, printed registration instruction pamphlet for how to receive secure lab results delivery online, and overnight return plastic shipping bag for transmitting medical specimens
First Use Anywhere:
Feb 18, 2022
First Use in Commerce:
Feb 18, 2022
Classification
International Classes
005